Anika Therapeutics, Inc. - COM (ANIK)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
12.7 M
Holdings value Q1 2024
$322 M
Value change Q1 2024
-$1.18 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
113
Number of buys Q1 2024
51
Number of sells Q1 2024
-51
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
035255108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 12.7 M $322 M -$1.18 M $25.40 113
2023 Q4 12.7 M $289 M +$1.23 M $22.66 112
2023 Q3 13 M $242 M -$5.56 M $18.63 114
2023 Q2 13.1 M $340 M +$436 K $25.98 115
2023 Q1 13.1 M $375 M -$1.05 M $28.72 118
2022 Q4 13.1 M $388 M -$23.8 M $29.60 122
2022 Q3 13.3 M $317 M -$2.36 M $23.80 111
2022 Q2 12.8 M $285 M -$1.57 M $22.32 115
2022 Q1 12.9 M $325 M +$2.54 M $25.11 109
2021 Q4 13.5 M $483 M +$10.3 M $35.83 124
2021 Q3 13.1 M $558 M -$406 K $42.56 126
2021 Q2 13.1 M $569 M -$4.32 M $43.29 134
2021 Q1 13.3 M $543 M -$15.1 M $40.79 143
2020 Q4 13.5 M $611 M +$252 K $45.26 154
2020 Q3 13.5 M $479 M -$7.3 M $35.39 151
2020 Q2 13.8 M $518 M +$35.1 M $37.73 154
2020 Q1 12.9 M $373 M -$23 M $28.91 152
2019 Q4 13.2 M $684 M -$12.1 M $51.85 183
2019 Q3 13.6 M $749 M -$19.5 M $54.89 187
2019 Q2 14 M $570 M +$37.4 M $40.62 164
2019 Q1 13.2 M $399 M +$13.1 M $30.24 150
2018 Q4 12.8 M $429 M -$13.5 M $33.61 154
2018 Q3 13.1 M $554 M -$31.4 M $42.18 152
2018 Q2 13.9 M $446 M +$47.6 M $32.00 161
2018 Q1 12.1 M $603 M +$11.4 M $49.72 163
2017 Q4 12.4 M $669 M -$3.46 M $53.91 163
2017 Q3 12.4 M $719 M +$3.28 M $58.00 163
2017 Q2 12.3 M $606 M +$28 M $49.34 153
2017 Q1 11.8 M $514 M +$108 M $43.44 152
2016 Q4 11 M $538 M -$2.61 M $48.96 152
2016 Q3 10.9 M $521 M -$20.6 M $47.85 159
2016 Q2 11.5 M $615 M -$30.8 M $53.65 157
2016 Q1 11.9 M $531 M -$11.2 M $44.72 157
2015 Q4 12.4 M $474 M -$3.26 M $38.16 148
2015 Q3 12.5 M $397 M +$11.1 M $31.83 133
2015 Q2 11.9 M $395 M -$15.2 M $33.03 134
2015 Q1 12.1 M $497 M +$17.8 M $41.17 156
2014 Q4 11.7 M $476 M +$37 M $40.74 158
2014 Q3 11 M $405 M +$34.1 M $36.66 151
2014 Q2 9.98 M $463 M -$6.56 M $46.33 160
2014 Q1 10.1 M $415 M +$53.5 M $41.10 151